Cash Strategies for Life Sciences Delays
By Andrew Levitch
The one constant when raising financing in a life sciences company is that it takes longer than initially forecasted. As previously shared in my colleague Patrick Nugent’s article about Life Sciences Financing Trends, it is taking twice as long to close a financing round (six months or more), and the length of time…Read More
Read MoreCreative Financing Approaches in Life Science
By Andrew Levitch, Mark Murray, Patrick Nugent, Linda Rubinstein
This article is the third in a 4-part series reviewing financing solutions for the Life Science sector. As Life Science company valuations have fluctuated significantly over the last two years, and investors have become cautious due to economic turbulence and market uncertainty, fundraising is taking longer. Equity financing has been…Read More
Read MoreAdvice for Life Sciences Companies Going Commercial for the First Time
By Jim Mackaness
Life sciences companies going commercial for the first time have the opportunity to create significant shareholder value – but the path to achieving this milestone will likely be volatile. The words that best sum up my advice to management teams and boards at life sciences companies that embark on the…Read More
Read More